74
Views
0
CrossRef citations to date
0
Altmetric

REFERENCES

  • Mroueh R, Haapaniemi A, Grénman R, et al. Improved outcomes with oral tongue squamous cell carcinoma in Finland. Head Neck 2017 Jul;39(7):1306–1312. doi: 10.1002/hed.24744. Epub 2017 May 8.
  • Chen SW, Zhang Q, Guo ZM, et al. Trends in clinical features and survival of oral cavity cancer: 50 years of experience with 3,362 consecutive cases from a single institution. Cancer Manag Res 2018 Oct 12;10:4523–4535. doi: 10.2147/CMAR.S171251. eCollection 2018.
  • Wong CH, Wei FC. Microsurgical free flap in head and neck reconstruction. Head Neck 2010 Sep;32(9):1236–45. doi: 10.1002/hed.21284.
  • Stark B, Nathanson A, Hedén P, Jernbeck J. Results after resection of intraoral cancer and reconstruction with the free radial forearm flap. ORL J Otorhinolaryngol Relat Spec Jul–Aug 1998;60(4):212–7. doi: 10.1159/000027596.
  • Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma — the University of Iowa Experience. Int J Radiat Oncol Biol Phys 2005 Oct 1;63(2):410–21. doi: 10.1016/j.ijrobp.2005.02.025.
  • Werner JA, Gottschlich S. Recent advances: Otorhinolaryngology. BMJ 1997 Aug 9;315(7104):354–7. doi: 10.1136/bmj.315.7104.354.
  • Hashim DE, Genden M, Posner M, Hashibe M, Boffetta P. Head and neck cancer prevention: From primary prevention to impact of clinicians on reducing burden. Ann Oncol 2019 May 1;30(5):744–756. doi: 10.1093/annonc/mdz084.
  • Näsman A, Du J, Dalianis T. A global epidemic increase of an HPV induced tonsil and tongue base cancer — potential benefit from a pangender use of HPV vaccine. J Intern Med 2020 Feb;287(2):134–152. doi: 10.1111/joim.13010. Epub 2019 Dec 9.
  • Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol 2016 Jan 10;34(2):169–78. doi: 10.1200/JCO.2015.61.5906. Epub 2015 Nov 30.
  • Fisher SE. Delays in referral and treatment of oral cancer. Br Dent J 200 Mar 188(5):258–258. http://doi.org/10.1038/sj.bdj.4800446.
  • National Comprehensive Cancer Network. NCCN Guidelines for Head and Neck Cancer, version 1.2020.
  • Mistry RC, Qureshi SS, Kumaran C. Postresection mucosal margin shrinkage in oral cancer: Quantification and significance. J Surg Oncol 2005 Aug 1;91(2):131–3. doi: 10.1002/jso.20285.
  • Melchers LJ, Schuuring E, van Dijk BAC, et al. Tumor infiltration depth ≥ 4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 2012 Apr;48(4):337–42. doi: 10.1016/j.oraloncology.2011.11.007. Epub 2011 Nov 29.
  • Monroe MM, Gross ND. Evidence based practice: Management of the clinical node negative neck in early stage oral cavity squamous cell carcinoma. Otolaryngol Clin North Am 2012 Oct;45(5):1181–93. doi: 10.1016/j.otc.2012.06.016.
  • Zhan KY, Eskander A, Kang SY, et al. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol 2017 Oct;73:152–159. doi: 10.1016/j.oraloncology.2017.08.020. Epub 2017 Sep 7.
  • Mazzola R, Fiorentino A, Ricchetti F, et al. 2018. An update on radiation therapy in head and neck cancers. Expert Rev Anticancer Ther 2018 Apr;18(4):359–364. doi: 10.1080/14737140.2018.1446832. Epub 2018 Mar 1.
  • Krueger SA, Wilson GD, Piasentin E, et al. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. Int J Radiat Oncol Biol Phys 2010 Aug 1;77(5):1509–17. doi: 10.1016/j.ijrobp.2010.01.028.
  • Shrieve DC, Loeffler JS, eds. Human Radiation Injury. Philadelphia: Lippincott Williams & Wilkins; 2010.
  • Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: Current advances and future directions. Int J Med Sci 2012;9(3):193–9. doi: 10.7150/ijms.3635. Epub 2012 Feb 27.
  • Yeh SA. Radiotherapy for head and neck cancer. Semin Plast Surg 2010 May; 24(2):127–136. doi: 10.1055/s-0030-1255330.
  • Mazzola R, Ricchetti F, Fiorentino S, et al. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. Br J Radiol 2014 Dec;87(1044):20140543. doi: 10.1259/bjr.20140543. Epub 2014 Oct 28.
  • Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999 Dec 15;91(24):2081–6. doi: 10.1093/jnci/91.24.2081.
  • Weichselbaum RR, Liang H, Deng L, et al. Radiotherapy and immunotherapy: A beneficial liaison? Nat Rev Clin Oncol 2017 Jun;14(6):365–379. doi: 10.1038/nrclinonc.2016.211. Epub 2017 Jan 17.
  • Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007 Oct 25;357(17):1705–15. doi: 10.1056/NEJMoa070956.
  • Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008 Sep 11;359(11):1116–27. doi: 10.1056/NEJMoa0802656.
  • Oosting SF, Haddad RI. Best practice in systemic therapy for head and neck squamous cell carcinoma. Front Oncol 2019 Aug 27;9:815. doi: 10.3389/fonc.2019.00815. eCollection 2019.
  • Denaro N, Merlano M. Immunotherapy in head and neck squamous cell cancer. Clin Exp Otorhinolaryngol 2018 Dec;11(4):217–223. doi: 10.21053/ceo.2018.00150.
  • Kulangara K, Zhang N, Corigliano E, et al. Clinical utility of the combined positive score for programmed death ligand-1 expression and the approval of pembrolizumab for treatment of gastric cancer. Arch Pathol Lab Med 2019 Mar;143(3):330–337. doi: 10.5858/arpa.2018-0043-OA. Epub 2018 Jul 20.
  • Rischin D, Harrington KJ, Greil R, et al. Protocol-specified final analysis of the phase 3 keynote-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). J Clin Oncol 2019 May;37(15_suppl):6000–6000. doi: 10.1200/JCO.2019.37.15_suppl.6000.
  • U.S. Food and Drug Administration. FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma. www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-first-line-treatment-head-and-neck-squamous-cell-carcinoma.
  • Bell RB, Leidner RS, Crittenden MR, et al. OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment. Oral Oncol 2016 Jan;52:1–10. doi: 10.1016/j.oraloncology.2015.11.009. Epub 2015 Nov 21.
  • Bell RB, Duhen R, Leidner RS, et al. Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma. J Clin Oncol 36 (15_suppl):6011–6011. doi: 10.1200/JCO.2018.36.15_suppl.6011.
  • Barber GN. STING: Infection, inflammation and cancer. Nat Rev Immunol 2015 Dec;15(12):760–70. doi: 10.1038/nri3921.
  • National Institutes of Health. Evaluating safety and efficacy of SB 11285 alone and in combination with atezolizumab in patients with advanced solid tumors. clinicaltrials.gov/ct2/show/study/NCT04096638.
  • Chow LQM. Head and neck cancer. N Engl J Med 2020 Jan 2;382(1):60–72. doi: 10.1056/NEJMra1715715.
  • NCCN Clinical practice guidelines in oncology, head and neck cancers, version 1.2020. Feb. 12, 2020. www.nccn.org/professionals/physician_gls/default.aspx.
  • Cheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Untreated oral cavity cancer: Long term survival and factors associated with treatment refusal. Laryngoscope 2018 Mar;128(3):664–669. doi: 10.1002/lary.26809. Epub 2017 Sep 2.
  • Sowder JC, Cannon RB, Buchmann LO, et al. Treatment related determinants of survival in early stage (T1-2N0M0) oral cavity cancer: A population based study. Head Neck 2017 May;39(5):876–880. doi: 10.1002/hed.24679. Epub 2017 Feb 25.
  • Chaturvedi P, Datta S, Nair S, et al. Gross examination by the surgeon as an alternative to frozen section for assessment of adequacy of surgical margin in head and neck squamous cell carcinoma. Head Neck 2014 Apr;36(4):557–63. doi: 10.1002/hed.23313. Epub 2013 Jun 14.
  • Zuniga JR. Sensory outcomes after reconstruction of lingual and inferior alveolar nerve discontinuities using processed nerve allograft — a case series. J Oral Maxillofac Surg 2015 Apr;73(4):734–44. doi: 10.1016/j.joms.2014.10.030. Epub 2014 Nov 13.
  • Zuniga JR, Williams F, Petrisor D. A case-and-control, multisite, positive-controlled, prospective study of the safety and effectiveness of immediate inferior alveolar nerve processed nerve allograft reconstruction with ablation of the mandible for benign pathology. J Oral Maxillofac Surg 2017 Dec;75(12):2669–2681. doi: 10.1016/j.joms.2017.04.002. Epub 2017 Apr 13.
  • Gidley PW, Herrera SJ, Hanasono MM, et al. The impact of radiotherapy on facial nerve repair. Laryngoscope 2010 Oct;120(10):1985–9. doi: 10.1002/lary.21048.
  • Yampolsky A, Ziccardi V, Sung-Kiang SK. Efficacy of acellular nerve allografts in trigeminal nerve reconstruction. J Oral Maxillofac Surg 2017 Oct;75(10):2230–2234. doi: 10.1016/j.joms.2017.02.015. Epub 2017 Feb 27.
  • Gabrysz-Forget F, Tabet P, Rahal A, et al. Free versus pedicled flaps for reconstruction of head and neck cancer defects: A systematic review. J Otolaryngol Head Neck Surg 2019 Mar 14;48(1):13. doi: 10.1186/s40463-019-0334-y.
  • Canis M, Weiss BG, Ihler F, et al. Quality of life in patients after resection of pT3 lateral tongue carcinoma: Microvascular reconstruction versus primary closure. Head Neck 2016 Jan;38(1):89–94. doi: 10.1002/hed.23862. Epub 2015 Jun 16.
  • Hanasono MM, Friel MT, Klem C, et al. Impact of reconstructive microsurgery in patients with advanced oral cavity cancers. Head Neck 2009 Oct;31(10):1289–96. doi: 10.1002/hed.21100.
  • Nakatsuka T, Harii K, Asato H, et al. 2003. Analytic review of 2,372 free flap transfers for head and neck reconstruction following cancer resection. J Reconstr Microsurg 2003 Aug;19(6):363–8; discussion 369. doi: 10.1055/s-2003-42630.
  • Urken ML, Moscoso JF, Lawson W, Biller HF. A systemic approach to functional reconstruction of the oral cavity following partial and total glossectomy. Arch Otolaryngol Head Neck Surg 1994 Jun;120(6):589–601. doi: 10.1001/archotol.1994.01880300007002.
  • Meier J, Schuderer J, Zeman F, et al. Health-related quality of life: A retrospective study on local vs. microvascular reconstruction in patients with oral cancer. BMC Oral Health 2019 Apr 27;19(1):62. doi: 10.1186/s12903-019-0760-2.
  • Sharaf B, Levine J, Hirsch D, et al. Importance of computer-aided design and manufacturing technology in the multidisciplinary approach to head and neck reconstruction. J Craniofac Surg 2010 Jul;21(4):1277–80. doi: 10.1097/SCS.0b013e3181e1b5d8.
  • Patel A, Harrison P, Cheng A, Bray B, Bell RB. Fibular reconstruction of the maxilla and mandible with immediate implant supported prosthetic rehabilitation: Jaw in a day. Oral Maxillofac Surg Clin North Am 2019 Aug;31(3):369–386. doi: 10.1016/j.coms.2019.03.002. Epub 2019 Jun 1.
  • Samouhi P, Buchbinder D. Rehabilitation of oral cancer patients with dental implants. Curr Opin Otolaryngol Head Neck Surg 2000 Aug;8(4):305–313. doi: 10.1097/00020840-200008000-00006.
  • Urken ML, Buchbinder D, Weinberg H, et al. Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: A comparative study of reconstructed and nonreconstructed patients. Laryngoscope 2015 Jul;125(7):1512. doi: 10.1002/lary.25279.
  • Qaisi M, Kolodney H, Swedenburg G, et al. Fibula jaw in a day: State of the art in mandibular reconstruction. J Oral Maxillofac Surg 2016 Jun;74(6):1284.e1–1284.e15. doi: 10.1016/j.joms.2016.01.047. Epub 2016 Feb 1.
  • Tolomeo PG, Lee JS, Caldroney SJ, et al. Clinical outcome of jaw-in-a-day total maxillofacial reconstruction. J Oral Maxillofac Surg 2015 Sep;73(9):e73–e73. http://doi.org/10.1016/j.joms.2015.06.129.
  • Grewal AS, Erovic B, Strumas N, et al. The utility of the microvascular anastomotic coupler in free tissue transfer. Can J Plast Surg Summer 2012;20(2):98–102. doi: 10.1177/229255031202000213.
  • Chang EI, Chu CK, Chang EI. Advancements in imaging technology for microvascular free tissue transfer. J Surg Oncol 2018 Oct;118(5):729–735. doi: 10.1002/jso.25194. Epub 2018 Sep 9.
  • Li MM, Tamaki A, Seim NB, Kang SY, et al. Utilization of microvascular couplers in salvage arterial anastomosis in head and neck free flap surgery: Case series and literature review. Head Neck 2020 Mar;42(6). doi: 10.1002/hed.26139.
  • Sando IC, Plott JS, McCracken BM, et al. Simplifying arterial coupling in microsurgery — a preclinical assessment of an everter device to aid with arterial anastomosis. J Reconstr Microsurg 2018 Jul;34(6):420–427. doi: 10.1055/s-0038-1626691. Epub 2018 Feb 16.
  • Hitier M, Cracowski JL, Hamou C, Righini C, Bettega G. Indocyanine green fluorescence angiography for free flap monitoring: A pilot study. J Craniomaxillofac Surg 2016 Nov;44(11):1833–1841. doi: 10.1016/j.jcms.2016.09.001. Epub 2016 Sep 10.
  • Klifto KM, Milek D, Gurno CF, et al. Comparison of arterial and venous implantable doppler postoperative monitoring of free flaps: Systematic review and meta-analysis of diagnostic test accuracy. Microsurgery 2020 May;40(4):501–511. doi: 10.1002/micr.30564. Epub 2020 Feb 7.
  • Mücke T, Hapfelmeier A, Schmidt LH, et al. A comparative analysis using flowmeter, laser-doppler spectrophotometry and indocyanine green-videoangiography for detection of vascular stenosis in free flaps. Sci Rep 2020 Jan 22;10(1):939. doi: 10.1038/s41598-020-57777-2.
  • Bastos P, Fry A, Cascarini L, Yeung E, Cook R. Real-time optical vascular imaging: A method to assess the microvascular circulation of myofascial free flaps used in the head and neck region. Int J Oral and Maxillofac Surg May 49(5):582–586. http://doi.org/10.1016/j.ijom.2019.11.005.
  • Shimura S, Ogi K, Miyazaki A, et al. Selective neck dissection and survival in pathologically node-positive oral squamous cell carcinoma. Cancers (Basel) 2019 Feb 25;11(2):269. doi: 10.3390/cancers11020269.
  • Rodrigo JP, Grilli G, Shah JP, et al. Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review. Eur J Surg Oncol 2018 Apr;44(4):395–403. doi: 10.1016/j.ejso.2018.01.003. Epub 2018 Jan 11.
  • Givi B, Linkov G, Ganly I, et al. Selective neck dissection in node-positive squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2012 Oct;147(4):707–15. doi: 10.1177/0194599812444852. Epub 2012 Apr 18.
  • McLean T, Kerr SJ, Giddings CEB. Prophylactic dissection of level V in primary mucosal SCC in the clinically N positive neck: A systematic review. Laryngoscope 2017 Sep;127(9):2074–2080. doi: 10.1002/lary.26573. Epub 2017 Apr 14.
  • Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994 Jul;120(7):699–702. doi: 10.1001/archotol.1994.01880310005001.
  • D’Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 2015 Aug;373(6):521–529. doi: 10.1056/NEJMoa1506007.
  • Montes DM, Schmidt BL. Oral maxillary squamous cell carcinoma: Management of the clinically negative neck. J Oral Maxillofac Surg 2008 Apr;66(4):762–6. doi: 10.1016/j.joms.2007.12.017.
  • Simental AA, Johnson JT, Myers EN. Cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate. Laryngoscope 2006 Sep;116(9):1682–4. doi: 10.1097/01.mlg.0000233607.41540.28.
  • Montes DM, Carlson ER, Fernandes R, et al. Oral maxillary squamous carcinoma: An indication for neck dissection in the clinically negative neck. Head Neck 2011 Nov;33(11):1581–5. doi: 10.1002/hed.21631. Epub 2010 Dec 6.
  • Brockhoff HC, Kim RY, Braun TM, et al. Correlating the depth of invasion at specific anatomic locations with the risk for regional metastatic disease to lymph nodes in the neck for oral squamous cell carcinoma: Correlating the depth of invasion to lymph nodes for oral SCC. Head Neck 2017 May;39(5):974–979. doi: 10.1002/hed.24724. Epub 2017 Feb 25.
  • Spiro RH, Huvos AG, Wong GY, et al. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986 Oct;152(4):345–50. doi: 10.1016/0002-9610(86)90302-8.
  • Mølstrøm J, Grønne M, Green A, Bakholdt V, Sørensen JA. Topographical distribution of sentinel nodes and metastases from T1–T2 oral squamous cell carcinomas. Eur J Cancer 2019 Jan;107:86–92. doi: 10.1016/j.ejca.2018.10.021. Epub 2018 Dec 12.
  • Schilling C, Stoeckli SJ, Vigili MG, et al. Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer. Head Neck 2019 Aug;41(8):2655–2664. doi: 10.1002/hed.25739. Epub 2019 Mar 21.
  • Gangwani K, Shetty L, Seshagiri R, Kulkarni D. Comparison of TORS with conventional surgery for oropharyngeal carcinomas in T1-T4 lesions. Ann Maxillofac Surg Jul–Dec 2019;9(2):387–392. doi: 10.4103/ams.ams_33_184.
  • Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M. Oncologic, functional and surgical outcomes of primary transoral robotic surgery for early squamous cell cancer of the oropharynx: A systematic review. Oral Oncol 2014 Aug;50(8):696–703. doi: 10.1016/j.oraloncology.2014.04.005. Epub 2014 Jun 7.
  • Baliga S, Kabarriti R, Jiang J, et al. Utilization of transoral robotic surgery (TORS) in patients with oropharyngeal squamous cell carcinoma and its impact on survival and use of chemotherapy. Oral Oncol 2018 Nov;86:75–80. doi: 10.1016/j.oraloncology.2018.06.009. Epub 2018 Sep 15.
  • Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic review. Laryngoscope 2014 Sep;124(9):2096–102. doi: 10.1002/lary.24712. Epub 2014 May 27.
  • U.S. Department of Health and Human Services. Dental Provider’s Oncology Pocket Guide. 2009. National Institute of Dental and Craniofacial Research. National Oral Health Information Clearinghouse. www.nidcr.nih.gov.
  • Manzano BR, Santaella NG, Oliveira MA, et al. Retrospective study of osteoradionecrosis in the jaws of patients with head and neck cancer. J Korean Assoc Oral and Maxillofac Surg 2019 45;(1):21–28. doi: 10.5125/jkaoms.2019.45.1.21.
  • Bradley JC. The clinical significance of age changes in the vascular supply to the mandible. Int J Oral Surg 1981;10(Suppl 1):71–6.
  • Nadella KR, Kodali RM, Guttikonda LK, Jonnalagadda A. Osteoradionecrosis of the jaws: Clinico-therapeutic management: A literature review and update. J Maxillofac Oral Surg 2015 Dec;14(4):891–901. doi: 10.1007/s12663-015-0762-9. Epub 2015 Mar 10.
  • Breik O, Tocaciu S, Briggs K, Tasfia Saief S, Richardson S. Is there a role for pentoxifylline and tocopherol in the management of advanced osteoradionecrosis of the jaws with pathological fractures? Case reports and review of the literature. Int J Oral Maxillofac Surg 2019 Aug;48(8):1022–1027. doi: 10.1016/j.ijom.2019.03.894. Epub 2019 Apr 10.
  • Ceponis P, Keilman C, Guerry C, Freiberger JJ. Hyperbaric oxygen therapy and osteonecrosis. Oral Dis 2016 Apr;23(2):141–151. http://doi.org/10.1111/odi.12489.
  • Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 2004 Dec 15;22(24):4893–900. doi: 10.1200/JCO.2004.09.006. Epub 2004 Nov 1.
  • Bulsara VM, Bulsara MK, Lewis E. Protocol for prospective randomized assessor-blinded pilot study comparing hyperbaric oxygen therapy with PENtoxifylline + Tocopherol – CLOdronate for the management of early osteoradionecrosis of the mandible. BMJ Open 2019 Mar;9(3):e026662. http://doi.org/10.1136/bmjopen-2018-026662.
  • Fischer DJ, Epstein JB. Management of patients who have undergone head and neck cancer therapy. Dent Clin North Am 2008 Jan;52(1):39–60, viii. doi: 10.1016/j.cden.2007.09.004.
  • Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head and neck cancer treatment: Patients’ perspectives. Otolaryngol Head Neck Surg 2011 Nov;145(5):767–71. doi: 10.1177/0194599811414506. Epub 2011 Jul 11.
  • Tanigawa T, Yamashita J, Sato T, et al. Efficacy and safety of pilocarpine mouthwash in elderly patients with xerostomia. Spec Care Dentist Jul–Aug 2015;35(4):164–9. doi: 10.1111/scd.12105. Epub 2015 Feb 2.
  • Laffleur F, Röttges S. Buccal adhesive chitosan conjugate comprising pilocarpine for xerostomia. Int J Biol Macromol 2019 Aug 15;135:1043–1051. doi: 10.1016/j.ijbiomac.2019.05.219. Epub 2019 May 31.
  • Chow L. Head and neck cancer. N Engl J Med 2020 Jan 2;382(1):60–72. doi: 10.1056/NEJMra1715715.
  • Alsahafi E, Begg K, Amelio I, et al. Clinical update on head and neck cancer: Molecular biology and ongoing challenges. Cell Death Dis 2019 Jul 15;10(8):540. doi: 10.1038/s41419-019-1769-9.
  • Kademani D, ed. Improving Outcomes in Oral Cancer: A Clinical and Translational Update. Cham, Switzerland: Springer; 2020.
  • Marcu LG, Boyd C, Bezak E. Feeding the data monster: Data science in head and neck cancer for personalized therapy. J Am Coll Radiol 2019 Dec;16(12):1695–1701. doi: 10.1016/j.jacr.2019.05.045. Epub 2019 Jun 22.
  • Yan S, Luo Z, Li Z, et al. Improving cancer immunotherapy outcomes using biomaterials. Angew Chem Int Ed Engl 2020 Apr 15. doi: 10.1002/anie.202002780. Online ahead of print.
  • Greenspan JS, Warnakulasuriya J, eds. Textbook of Oral Cancer: Prevention, Diagnosis and Management. Cham, Switzerland: Springer; 202:395–396.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.